Issue : The Pharmaceutical Journal, July 2011
Sort by: Newest first Oldest first A-Z Z-A
-
New NHS information web portal launched
Patients and healthcare professionals can now exchange and use information through a web portal launched this week (25 July 2011).
-
COPD quality standard published by NICE
A new quality standard on chronic obstructive pulmonary disease has been published by the National Institute for Health and Clinical Excellence.
-
Retigabine approved for epilepsy
Retigabine has been approved for controlling seizures in adults with epilepsy by the National Institute for Health and Clinical Excellence.
-
NICE approves dexamethasone for macular oedema
Dexamethasone has been approved in England and Wales for the treatment of patients with macular oedema by the National Institute for Health and Clinical Excellence.
-
Preregistration trainees claim exam conditions affected performance
More than 70 preregistration trainees have complained to their student body because they are concerned that increased stress levels might have affected their performance in this year’s registration examination. They say their increased stress was brought about because of the way the examination was organised.
-
Professionals should be prepared to whistle-blow or risk investigation
Health regulators should send a clear signal to professionals that they may be investigated if they fail to raise concerns about colleagues, MPs have indicated. That view is supported by the General Pharmaceutical Council.
-
Pharmaceutical scientists welcomed into Society’s fold
Pharmaceutical scientists will be able to join the Royal Pharmaceutical Society from October following a vote by RPS members. A special resolution ballot achieved a voter turnout of 8,806 members (24.8 per cent), with 76 per cent voting in favour of creating an RPS pharmaceutical scientist membership category.
-
Limited opportunities in first wave of patient choice reforms
Diagnostic services and home chemotherapy care are two areas where community pharmacists could provide services under Government plans to open up the NHS to "any qualified provider" (AQP), according to the Pharmaceutical Services Negotiating Committee.
